G
42.60
-0.54 (-1.25%)
| Penutupan Terdahulu | 43.14 |
| Buka | 41.80 |
| Jumlah Dagangan | 1,669,141 |
| Purata Dagangan (3B) | 2,378,813 |
| Modal Pasaran | 5,328,152,064 |
| Harga / Jualan (P/S) | 7.26 |
| Harga / Buku (P/B) | 55.67 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2025 - 12 May 2025 |
| Margin Keuntungan | -59.05% |
| Margin Operasi (TTM) | -62.79% |
| EPS Cair (TTM) | -3.56 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 30.20% |
| Nisbah Semasa (MRQ) | 4.68 |
| Aliran Tunai Operasi (OCF TTM) | -239.86 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -146.83 M |
| Pulangan Atas Aset (ROA TTM) | -16.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -4,584.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menurun | Menurun |
| Diagnostics & Research (Global) | Menurun | Menurun | |
| Stok | Guardant Health, Inc. | Bercampur | Menaik |
AISkor Stockmoo
-1.4
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | -4.0 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -1.40 |
|
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.79% |
| % Dimiliki oleh Institusi | 100.60% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 60.00 (Canaccord Genuity, 40.85%) | Beli |
| Median | 55.00 (29.11%) | |
| Rendah | 50.00 (Piper Sandler, 17.37%) | Beli |
| Purata | 54.83 (28.71%) | |
| Jumlah | 12 Beli | |
| Harga Purata @ Panggilan | 42.52 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 10 Apr 2025 | 55.00 (29.11%) | Beli | 41.14 |
| 23 Jan 2025 | 60.00 (40.85%) | Beli | 48.60 | |
| Mizuho | 10 Apr 2025 | 55.00 (29.11%) | Beli | 41.14 |
| Stephens & Co. | 26 Mar 2025 | 55.00 (29.11%) | Beli | 45.84 |
| Morgan Stanley | 06 Mar 2025 | 52.00 (22.07%) | Beli | 40.17 |
| Piper Sandler | 26 Feb 2025 | 50.00 (17.37%) | Beli | 43.19 |
| Canaccord Genuity | 24 Feb 2025 | 60.00 (40.85%) | Beli | 42.44 |
| Guggenheim | 24 Feb 2025 | 56.00 (31.46%) | Beli | 42.44 |
| Scotiabank | 24 Feb 2025 | 52.00 (22.07%) | Beli | 42.44 |
| Goldman Sachs | 21 Feb 2025 | 56.00 (31.46%) | Beli | 42.87 |
| 28 Jan 2025 | 49.00 (15.02%) | Beli | 48.26 | |
| JP Morgan | 21 Feb 2025 | 55.00 (29.11%) | Beli | 42.87 |
| Raymond James | 21 Feb 2025 | 59.00 (38.50%) | Beli | 42.87 |
| Stifel | 21 Feb 2025 | 53.00 (24.41%) | Beli | 42.87 |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BELL MICHAEL BRIAN | - | 42.47 | -1,057 | -44,891 |
| CHUDOVA DARYA | - | 42.47 | -1,524 | -64,724 |
| EAGLE CRAIG | - | 42.47 | -1,295 | -54,999 |
| ELTOUKHY HELMY | - | 42.54 | -14,603 | -620,507 |
| FREEMAN CHRIS | - | 42.47 | -1,106 | -46,972 |
| JOYCE MEGHAN V. | - | - | 0 | 0 |
| KALIA KUMUD | - | 42.47 | -961 | -40,814 |
| KROGNES STEVE E. | - | - | 0 | 0 |
| SAIA JOHN G. | - | 42.47 | -1,360 | -57,759 |
| TALASAZ AMIRALI | - | 42.54 | -14,603 | -620,507 |
| Jumlah Keseluruhan Kuantiti Bersih | -36,509 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,551,172 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 42.50 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| JOYCE MEGHAN V. | Pengarah | 04 Apr 2025 | Pelaksanaan pilihan | 66 | - | - |
| ELTOUKHY HELMY | Pegawai | 01 Apr 2025 | Dibuang (-) | 12,163 | 42.47 | 516,563 |
| ELTOUKHY HELMY | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 23,998 | - | - |
| TALASAZ AMIRALI | Pegawai | 01 Apr 2025 | Dibuang (-) | 12,163 | 42.47 | 516,563 |
| TALASAZ AMIRALI | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 23,998 | - | - |
| BELL MICHAEL BRIAN | Pegawai | 01 Apr 2025 | Dibuang (-) | 1,057 | 42.47 | 44,891 |
| BELL MICHAEL BRIAN | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 2,084 | - | - |
| CHUDOVA DARYA | Pegawai | 01 Apr 2025 | Dibuang (-) | 1,524 | 42.47 | 64,724 |
| CHUDOVA DARYA | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 3,006 | - | - |
| EAGLE CRAIG | Pegawai | 01 Apr 2025 | Dibuang (-) | 1,295 | 42.47 | 54,999 |
| EAGLE CRAIG | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 3,381 | - | - |
| FREEMAN CHRIS | Pegawai | 01 Apr 2025 | Dibuang (-) | 1,106 | 42.47 | 46,972 |
| FREEMAN CHRIS | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 3,595 | - | - |
| KALIA KUMUD | Pegawai | 01 Apr 2025 | Dibuang (-) | 961 | 42.47 | 40,814 |
| KALIA KUMUD | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 2,691 | - | - |
| SAIA JOHN G. | Pegawai | 01 Apr 2025 | Dibuang (-) | 1,360 | 42.47 | 57,759 |
| SAIA JOHN G. | Pegawai | 01 Apr 2025 | Pelaksanaan pilihan | 2,641 | - | - |
| ELTOUKHY HELMY | Pegawai | 31 Mar 2025 | Dibuang (-) | 2,440 | 42.60 | 103,944 |
| ELTOUKHY HELMY | Pegawai | 31 Mar 2025 | Pelaksanaan pilihan | 4,814 | - | - |
| TALASAZ AMIRALI | Pegawai | 31 Mar 2025 | Dibuang (-) | 2,440 | 42.60 | 103,944 |
| TALASAZ AMIRALI | Pegawai | 31 Mar 2025 | Pelaksanaan pilihan | 4,814 | - | - |
| KROGNES STEVE E. | Pengarah | 31 Mar 2025 | Pelaksanaan pilihan | 154 | - | - |
| Papar semua | ||||||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |